This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Ways To Manage Unexpected Costs shares smart strategies to track expenses, reduce leakage, and prepare an emergency fund for surprises.
21,677 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Oro Labs has secured a $100 million Series C to scale its AI-powered procurement orchestration platform, expanding it...
A growing cohort of retirees is buying into the Taiwan-centric ETF EWT to capture gains from Taiwan’s chipmakers. The...
The Ethereum Foundation has quietly moved 5,000 ETH to BitMine in a $10 million over-the-counter trade, marking its s...
Chip stocks are back in the spotlight as AI and data demand push hardware needs higher. This article weighs Micron ag...
Solana’s stablecoin liquidity reached a new peak in February 2026, while open interest rose to near $6 billion, signa...
Big tech is pouring hundreds of billions into AI infrastructure. This creates opportunities for selective stocks. Lea...
IBM has delivered a multiyear rally, but a 2026 pullback creates a buying opportunity for patient investors. This gui...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
As SpaceX moves closer to a historic IPO, investors are eyeing space peers for immediate upside. This report highligh...
As Lumentum and Coherent rally, Onto Innovation could be the next optics supplier to gain. Analysts say the surge ref...
As software shares pull back in 2026, you don’t have to chase chaos. This article identifies one software stock actua...